Phearavin Pheng

Dependence of Efavirenz- and Rifampicin-Isoniazid–Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms: ANRS 12154 Study in Cambodia

Julie Bertrand, Céline Verstuyft, Monidarin Chou et al. · The Journal of Infectious Diseases · 2013 · 50 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study

Olivier Marcy, Mathurin Cyrille Tejiokem, Philippe Msellati et al. · The Lancet HIV · 2017 · 30 citations

Public Health, Infectious Diseases, Pediatrics +16

Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial)

Laurence Borand, Yoann Madec, Didier Laureillard et al. · PLoS ONE · 2014 · 18 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Plasma Concentrations of Efavirenz with a 600 Mg Standard Dose in Cambodian HIV-Infected Adults Treated for Tuberculosis with a Body Weight above 50 Kg

Laurence Borand, Didier Laureillard, Yoann Madec et al. · Antiviral Therapy · 2012 · 11 citations

Pharmacy, Infectious Diseases, Pharmacokinetics +15

Differences in prevalence and risk factors of non-communicable diseases between young people living with HIV (YLWH) and young general population in Cambodia

Kennarey Seang, Marjan Javanbakht, Sung‐Jae Lee et al. · PLoS ONE · 2022 · 11 citations · Full text

Public Health, Chronic Disease Prevention, Health Sciences +17